HERON THERAPEUTICS, INC. short interest in 2023
In 2023, HERON THERAPEUTICS, INC.'s disclosed short interest ran from 22.77% of shares outstanding on 13 Jan 2023 to 13.47% on 29 Dec 2023, a change of -9.30 percentage points. The year's high was 22.77% on 13 Jan 2023 and its low 11.72% on 15 Nov 2023, averaging 17.93% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 21.11 days on 14 Jul 2023. Full history: HERON THERAPEUTICS, INC..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 22.77% (13 Jan 2023)
- End of year
- 13.47% (29 Dec 2023)
- Change
- -9.30 pp
- High
- 22.77% (13 Jan 2023)
- Low
- 11.72% (15 Nov 2023)
- Average
- 17.93%
- Highest days to cover
- 21.11 (14 Jul 2023)
- SEC filings marked
- 9
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 22.77% | 16.99 | results (8-K) |
| 31 Jan 2023 | 22.53% | 15.03 | |
| 15 Feb 2023 | 21.98% | 15.31 | |
| 28 Feb 2023 | 19.57% | 14.11 | |
| 15 Mar 2023 | 19.12% | 14.58 | |
| 31 Mar 2023 | 19.41% | 10.22 | results (8-K), 10-K filed |
| 14 Apr 2023 | 19.44% | 5.63 | |
| 28 Apr 2023 | 18.70% | 13.17 | |
| 15 May 2023 | 18.16% | 7.01 | 10-Q filed, results (8-K) |
| 31 May 2023 | 19.61% | 8.97 | |
| 15 Jun 2023 | 19.20% | 10.94 | |
| 30 Jun 2023 | 18.81% | 11.35 | |
| 14 Jul 2023 | 18.63% | 21.11 | |
| 31 Jul 2023 | 17.27% | 9.16 | |
| 15 Aug 2023 | 19.72% | 10.64 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 17.99% | 17.36 | |
| 15 Sep 2023 | 18.29% | 17.79 | |
| 29 Sep 2023 | 18.71% | 16.54 | |
| 13 Oct 2023 | 13.75% | 5.51 | |
| 31 Oct 2023 | 13.08% | 9.75 | |
| 15 Nov 2023 | 11.72% | 4.27 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 14.38% | 4.75 | |
| 15 Dec 2023 | 14.00% | 7.53 | |
| 29 Dec 2023 | 13.47% | 10.02 |
See also: HERON THERAPEUTICS, INC.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.